An endovascular approach to cardioembolic stroke prevention in atrial fibrillation patients

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 7 II, 2003, Pages 1604-1606

  Nakai, Toshiko ^a,b   Lesh, Michael ^a,b   Ostermayer, Stefan ^d   Billinger, Kai ^d   Sievert, Horst ^a,c  

^a CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Appriva Medical   (United States)

^d NONE

Author keywords

Atrial fibrillation; Left atrial appendage; Stroke; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; ANALYTIC METHOD; ANAMNESIS; ANGIOGRAPHY; BLEEDING; CASE REPORT; CATHETER; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEVICE; DRUG TOLERANCE; EMBOLISM; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANT; LONG TERM CARE; MITRAL VALVE; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION; PULMONARY VEIN; RISK FACTOR; STROKE; SURFACE PROPERTY; SURGICAL TECHNIQUE; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VEIN BLOOD FLOW;

EID: 0037594886     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00238.x     Document Type: Conference Paper

References (11)

1. Wolf PA, Dawber TR, Thomas HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 1978; 28:973-977.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991; 22:983-988.
3. Atrial fibrillation Investigators. Risk for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154:1449-1457.
4. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1998; 81:755-759.
5. Belcher JR, Somerville W. Systemic embolism and left atriatricular thrombosis in relation to mitral stenosis. Br Med J 1955; 2:1000-1003.
6. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998; 128:639-847.
7. Johnson WD, Ganjoo AK, Stone CD, et al. The left atrial appendage: Our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg 2000; 17:718-722.
8. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Sur. 1991; 101:584-592.
9. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on management of patient with valvular heart disease). J Am Coll Cardiol 1998; 32:1488-1582.
10. Nakai T, Lesh MD, Gerstenfeld EP, et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism. First experience in canine model. Circulation 2002; 105:2217-2222.
11. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation - Early clinical experience. Circulation 105:1887-1889.